PROSTATIC DISEASES
Clinical trials for PROSTATIC DISEASES explained in plain language.
Never miss a new study
Get alerted when new PROSTATIC DISEASES trials appear
Sign up with your email to follow new studies for PROSTATIC DISEASES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New radioactive drug targets Hard-to-Treat prostate cancer
Disease control Recruiting nowThis study tests a new radioactive drug (177Lu-rhPSMA-10.1) in men with advanced prostate cancer that has spread and no longer responds to hormone therapy. The goal is to find the safest and most effective dose to shrink tumors or lower PSA levels. About 82 men will take part acr…
Matched conditions: PROSTATIC DISEASES
Phase: PHASE1, PHASE2 • Sponsor: Blue Earth Therapeutics Ltd • Aim: Disease control
Last updated May 17, 2026 03:56 UTC
-
New drug combo trial offers hope for Hard-to-Treat prostate cancer
Disease control Recruiting nowThis study tests a new drug called pocenbrodib, either by itself or combined with other treatments, in people with a type of advanced prostate cancer that no longer responds to hormone therapy. The goal is to find the safest dose and see if it helps shrink tumors or lower PSA lev…
Matched conditions: PROSTATIC DISEASES
Phase: PHASE1, PHASE2 • Sponsor: Pathos AI, Inc. • Aim: Disease control
Last updated May 12, 2026 13:39 UTC